Howard Capital Management Group’s iShares Biotechnology ETF IBB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $4.91M | Sell |
38,827
-840
| -2% | -$106K | 0.34% | 35 |
|
|
2025
Q1 | $5.07M | Sell |
39,667
-3,845
| -9% | -$492K | 0.4% | 33 |
|
|
2024
Q4 | $5.75M | Sell |
43,512
-80
| -0.2% | -$10.6K | 0.39% | 35 |
|
|
2024
Q3 | $6.35M | Sell |
43,592
-175
| -0.4% | -$25.5K | 0.45% | 34 |
|
|
2024
Q2 | $6.01M | Sell |
43,767
-415
| -0.9% | -$57K | 0.44% | 35 |
|
|
2024
Q1 | $6.06M | Sell |
44,182
-269
| -0.6% | -$36.9K | 0.47% | 35 |
|
|
2023
Q4 | $6.04M | Sell |
44,451
-570
| -1% | -$77.4K | 0.52% | 34 |
|
|
2023
Q3 | $5.51M | Sell |
45,021
-129
| -0.3% | -$15.8K | 0.53% | 34 |
|
|
2023
Q2 | $5.73M | Sell |
45,150
-356
| -0.8% | -$45.2K | 0.53% | 34 |
|
|
2023
Q1 | $5.88M | Hold |
45,506
| – | – | 0.62% | 32 |
|
|
2022
Q4 | $5.97M | Sell |
45,506
-335
| -0.7% | -$44K | 0.72% | 32 |
|
|
2022
Q3 | $5.36M | Sell |
45,841
-244
| -0.5% | -$28.5K | 0.68% | 32 |
|
|
2022
Q2 | $5.42M | Sell |
46,085
-175
| -0.4% | -$20.6K | 0.64% | 34 |
|
|
2022
Q1 | $6.03M | Sell |
46,260
-165
| -0.4% | -$21.5K | 0.55% | 36 |
|
|
2021
Q4 | $7.09M | Sell |
46,425
-150
| -0.3% | -$22.9K | 0.58% | 36 |
|
|
2021
Q3 | $7.53M | Sell |
46,575
-146
| -0.3% | -$23.6K | 0.7% | 35 |
|
|
2021
Q2 | $7.65M | Sell |
46,721
-950
| -2% | -$155K | 0.72% | 35 |
|
|
2021
Q1 | $7.18M | Buy |
+47,671
| New | +$7.18M | 0.75% | 35 |
|